Abstract
Sodium-glucose cotransporter 2 inhibitors, weight loss therapies, and ferric carboxymaltose: new light shed on innovative ways to reduce cardiovascular risk.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
